3781. Byetta-PSUSA-00009147-201503 3782. Ixiaro-H-C-PSUSA-00001801-201703 3783. Anoro-H-C-PSUSA-00010264-201512 3784. Yondelis-H-C-773-PSUV-0038 3785. Anoro-H-C-PSUSA-00010264-201506 3786. Fareston-H-C-PSUSA-00002999-201409: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation 3787. Hirobriz Breezhaler-H-C-PSUV-0023 3788. Briviact-H-C-PSUSA-00010447-201607 3789. Myozyme-H-C-PSUSA-00000086-201609 3790. Xeristar-573-H-C-A18-652 3791. Zonegran-H-C-PSUSA-00003152-202003: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation(s) 3792. Mayzent-PSUSA-00010818-202003: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation 3793. Yervoy-H-C-PSUSA-00009200-202003 3794. Tasigna-H-C-PSUSA-00002162-202001 3795. Dupixent-H-C-PSUSA-00010645-202009 3796. Ocrevus-H-C-PSUSA-00010662- 202003 3797. Bosulif-H-C-PSUSA-00010073-202003:EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation 3798. Saxenda-H-C-PSUSA-00001892-201912 3799. Victoza-H-C-1026-PSUSA-00001892-201912: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation 3800. Bydureon-H-C-PSUSA-00009147-202003 3801. Tegsedi-H-C-PSUSA-00010697-202101 3802. Brilique-PSUSA-00002948-20201: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation 3803. Stelara-H-C-PSUSA-00003085-202012 : Scientific conclusions and grounds for the variation to the terms of the marketing authorisation 3804. Truimeq-H-C-PSUSA-00010075-202101 3805. Lyrica-H-C-PSUSA-00002511-202101 3806. Jorveza-H-C-PSUSA-00010664-202101: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation 3807. Rybelsus-EMEA-H-C-PSUSA-00010671-202005 3808. Pregabalin Pfizer-H-C-PSUSA-00002511-202101: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation 3809. Esbriet-H-C-PSUSA-2435-202102 3810. Kevzara-H-C-PSUSA-00010609-202101: Scientific conclusions and grounds for the variation to the terms of the marketing authorisation(s)